Product information

From Health Canada

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Dormant

Current status date:

2022-06-15

Original market date: See footnote 1

2011-07-18

Product name:

CITRASATE C2125

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02366568

Product Monograph/Veterinary Labelling:

Date: 2021-01-14 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

CHIEF MEDICAL SUPPLIES LTD
411 19th St Se
Calgary
Alberta
Canada T2E 6J7

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Haemodialysis

Number of active ingredient(s):

7

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

40:34.00* See footnote6 

Anatomical Therapeutic Chemical (ATC): See footnote 4

B05ZA HEMODIALYTICS, CONCENTRATES

Active ingredient group (AIG) number:See footnote5

0752576003

List of active ingredient(s)
Active ingredient(s) Strength
CALCIUM CHLORIDE 6.24 G / L
CITRIC ACID 6.91 G / L
DEXTROSE 49.5 G / L
MAGNESIUM CHLORIDE 2.14 G / L
POTASSIUM CHLORIDE 6.71 G / L
SODIUM ACETATE 1.11 G / L
SODIUM CHLORIDE 263 G / L
Version 4.0.2
Date modified: